Last reviewed · How we verify
NCT05880199
BSGM to Evaluate Patients With GI Symptoms
trial testing Body surface gastric mapping device in Gastrointestinal Motility Disorders in Children in 685 participants. Currently enrolling.
31 December 2027
Quick facts
| Lead sponsor | Children's Hospital of Philadelphia |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 685 |
| Start date | 1 October 2021 |
| Primary completion | 31 December 2027 |
| Estimated completion | 30 June 2028 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- Body surface gastric mapping device
Conditions studied
- Gastrointestinal Motility Disorders in Children — all drugs for Gastrointestinal Motility Disorders in Children →
- Functional Gastrointestinal Disorders — all drugs for Functional Gastrointestinal Disorders →
- Gastroparesis — all drugs for Gastroparesis →
- Dyspepsia and Other Specified Disorders of Function of Stomach — all drugs for Dyspepsia and Other Specified Disorders of Function of Stomach →
Sponsor
Children's Hospital of Philadelphia
Who can join
Adults 8 to 25, any sex, with Gastrointestinal Motility Disorders in Children or Functional Gastrointestinal Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this observational study is to learn about gastric myoelectric activity in children with GI symptoms. The main question it aims to answer is which patterns or signals are associated with GI symptoms as measured by a body surface gastric mapping (BSGM) device. Participants will have their stomach activity recorded for up to 4 hours using the BSGM device and log real-time symptoms. Researchers will compare the recordings of healthy children and children with GI symptoms to define abnormal GI patterns.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05880199
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastrointestinal Motility Disorders in Children
Currently open trials in the same condition.
- NCT07519915 — Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Outcome Variables · NA · recruiting
Other Children's Hospital of Philadelphia trials
Trials by the same sponsor.
- NCT07023380 — EoE Food Test Pilot Study · NA · not yet recruiting
- NCT06693752 — CEUS Evaluation of Hydrocephalus in Neonates and Infants · Phase 2 · recruiting
- NCT07425691 — SPACE for Youth With Chronic Pain · recruiting
- NCT07444528 — Upper Airway Ultrasound to Predict Difficult Laryngoscopy in Neonates and Infants · enrolling by invitation
- NCT07321327 — Implementation Strategies for Caregiver and Teacher Use of Behavioral Interventions: Aim 2 · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05880199 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Children's Hospital of Philadelphia
- Last refreshed: 10 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880199.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing